Latest News in the pharma Industry

Biopharma News

FDA approves new Dupixent prefilled pen

FDA approves new Dupixent prefilled pen

23 Jun 2020

The prefilled pen supports more convenient self-administration for patients with chronic type 2 inflammatory diseases.

Read more 
CordenPharma & Moderna extend lipid supply agreement for Moderna’s coronavirus vaccine

CordenPharma & Moderna extend lipid supply agreement for Moderna’s coronavirus vaccine

23 Jun 2020

The amended manufacturing agreement, which originally specified CordenPharma facilities Switzerland, now extends to the CDMOs France and US sites.

Read more 
BIA Separations introduces PrimaS multi-mode ligand bioprocessing technology

BIA Separations introduces PrimaS multi-mode ligand bioprocessing technology

16 Jun 2020

Novel platform initially focussed on high-resolution industrial-scale processing of therapeutic mRNA.

Read more 
Sanofi to build EUR 490 million vaccine production facility in France

Sanofi to build EUR 490 million vaccine production facility in France

16 Jun 2020

The French pharma company will also invest EUR 120 million to create a new research center at Marcy-l'Etoile dedicated to vaccines

Read more 
Catalent inks deal with AstraZeneca to manufacture COVID-19 vaccine candidate

Catalent inks deal with AstraZeneca to manufacture COVID-19 vaccine candidate

15 Jun 2020

The company's Anagni, Italy facility will prepare to supply hundreds of millions of doses of the vaccine candidate if it's approved.

Read more 
WuXi Biologics signs lease for a clinical manufacturing facility in the US

WuXi Biologics signs lease for a clinical manufacturing facility in the US

9 Jun 2020

The deal represents the contract manufacturer's third US site.

Read more 
Fujifilm invests $928 million to expand CDMO's biologics production facility in Denmark

Fujifilm invests $928 million to expand CDMO's biologics production facility in Denmark

9 Jun 2020

Investment will double the site's drug substance manufacturing capacity and will expand its capabilities to include fill/finish, and enhance its current assembly, labeling and packaging services.

Read more 
Oxford Biomedica and VMIC seal UK vaccine manufacturing capacity deal

Oxford Biomedica and VMIC seal UK vaccine manufacturing capacity deal

8 Jun 2020

The collaboration will significantly increase the UK’s capacity to manufacture viral vectors vaccines as part of a national effort in response to COVID-19.

Read more 
Achilles Therapeutics to set up manufacturing operations at the CGT Catapult manufacturing centre

Achilles Therapeutics to set up manufacturing operations at the CGT Catapult manufacturing centre

8 Jun 2020

The collaboration with CGT Catapult will enable Achilles to increase its GMP manufacturing capacity to supply clinical trials of its novel T cell therapy products.

Read more 
Emergent BioSolutions signs 5-year manufacturing agreement for J&J’s lead COVID-19 vaccine candidate

Emergent BioSolutions signs 5-year manufacturing agreement for J&J’s lead COVID-19 vaccine candidate

6 Jul 2020

The CDMO produce drug substance at large scale for commercial manufacturing with the first 2 years valued at approximately $480 million.

Read more 
AGC Biologics acquires AstraZeneca commercial biomanufacturing facility

AGC Biologics acquires AstraZeneca commercial biomanufacturing facility

2 Jun 2020

The Boulder, Colorado, USA facility will increase global capacity and extend manufacturing scale.

Read more 
Emergent bags $628 million landmark CDMO deal to produce COVID-19 vaccine candidates

Emergent bags $628 million "landmark" CDMO deal to produce COVID-19 vaccine candidates

2 Jun 2020

The company will provide CDMO capabilities, capacities, and expertise to support the US government’s Warp Speed Program to pave the way for innovators to advance COVID-19 programs.

Read more